NLRP3 and myeloproliferative neoplasm: Notably, deficiency for NLRP3 decreased the frequency of HSCs expressing high levels of CD150 in murine MPN (Fig. 5c), suggesting that NLRP3 imparts a myeloid skew, in keeping with published data on IL-1β28.